Hospital 340B Program Recertification Begins August 17
The 340B Drug Pricing Program (340B Program) recertification period for hospital entities begins August 17, 2020, and continues through September 14, 2020. To remain in the 340B Program, hospitals are required by the Health Resources & Services Administration (HRSA) to acknowledge and attest to their entity account information in the 340B database. This recertification covers both parent entity and registered child sites where applicable.
HRSA suggests in its Annual Recertification FAQ that hospital Authorizing Officials and Primary Contacts review the 340B Office of Pharmacy Affairs Information System (OPAIS) records for accuracy prior to August 17. If changes to an entity’s 340B Program occur prior to the recertification period, it’s recommended to fill out a change request rather than wait for the recertification period. In addition, it’s important to ensure the Authorizing Official is updated, as the Authorizing Official will receive the email and user guide to begin the recertification process. Entities that fail to recertify within the period may be terminated from the 340B Program.
HRSA also recently released new registration and recertification requirements. In addition, the 340B OPAIS has been enhanced based on HRSA’s July 2020 update. The changes to the recertification process include the requirement to upload supporting documentation if changing the hospital classification selected when the parent hospital was registered. The Medicaid billing question also has been made more specific regarding Medicaid fee-for-service only. Other changes and enhancements are described in the July update.
To connect on this or other 340B Program topics, reach out to your BKD Trusted Advisor™ or use the Contact Us form below.